Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1999-03-20 till 1999-08-19
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline-conform study under GLP without deviations

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Methyl undec-10-enoate
EC Number:
203-910-8
EC Name:
Methyl undec-10-enoate
Cas Number:
111-81-9
Molecular formula:
C12H22O2
IUPAC Name:
methyl undec-10-enoate
Details on test material:
- Name of test material (as cited in study report): UNDECYLENATEDEMETHYLE
- Substance type: organic
- Physical state: liquid
- Analytical purity: 97.8 %
- Impurities (identity and concentrations):
- Purity test date: no data
- Lot/batch No.: 98 10006
- Expiration date of the lot/batch: July 1999
- Stability under test conditions: no data
- Storage condition of test material: at room temperature and protected from light
- Other:

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Iffa Crkdo, L'Arbresle, France.
- Age at study initiation: 8 weeks
- Weight at study initiation: 248 +/- 8 g for the males and 236 +/- 15 g for the females
- Fasting period before study: no data
- Housing: During the treatment period, the animals were housed individually in polycarbonate cages (35.5 cm x 23.5 cm x 19.3 cm). Each cage contained dust-free sawdust.
- Diet (e.g. ad libitum): All the animals had free access to A04 C pelleted diet (UAR, Villemoisson-sur-Orge, France)
- Water (e.g. ad libitum): Drinking water filtered by a FG Millipore membrane (0.22 micron) was provided ad libitum.
- Acclimation period: at least 5 days before the beginning of the study


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 +/- 2°C
- Humidity (%): 30 to 70%
- Air changes (per hr): approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12 h/12 h


IN-LIFE DATES: From: 1999-03-24 To: 1999-04-07

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: 5 cm x 6 cm for the females and 5 cm x 7 cm for the males
- % coverage: approximately 10% of the body surface of the animals
- Type of wrap if used: hydrophilic gauze pad


REMOVAL OF TEST SUBSTANCE
- Washing (if done): No residual test substance was observed at removal of the dressing.
- Time after start of exposure: not applicable


TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg body weight
- Concentration (if solution): undiluted
- Constant volume or concentration used: yes


VEHICLE
- Amount(s) applied (volume or weight with unit): not applicable
Duration of exposure:
24 h
Doses:
2000 mg/kg body weight
No. of animals per sex per dose:
5
Control animals:
not required
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: observation of the animals was made at least once a day until day 15. The animals were weighed individually just before administration of the test substance on day 1 and then on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology
Statistics:
no statistics applied

Results and discussion

Preliminary study:
As the test substance was anticipated to be non-toxic at 2000 mg/kg, a limit test was performed by application of 2000 mg/kg of the test substance to one group of ten animals
Effect levels
Sex:
male/female
Dose descriptor:
LD0
Effect level:
> 2 000 mg/kg bw
Mortality:
No death occurred during the study.
Clinical signs:
other: No clinical signs and no cutaneous reactions were observed during the study.
Gross pathology:
Macroscopic examination of the main organs of the animals revealed no apparent abnormalities.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: other: Guidance to Regulation (EC) No 1272/2008 on CLP of substances and mixtures
Conclusions:
Under the given experimental conditions, the dermal LDo of the test substance UNDECYLENATE DE METHYLE (batch No. 9810006) is equal to or higher than 2000 mg/kg in rats.
Executive summary:

The object of the study was to determine the acute dermal toxicity of test item UNDECYLENATE DE METHYLE according to OECD (No. 402, 24th February 1987) and EC (92/69/EEC, B.3, 31st July 1992) guidelines. Test subjects were male and female rats. Since the test substance was anticipated to be basically non-toxic, a fixed-dose limit test was carried out with a test item concentration of 2000 mg/kg. Under the given experimental conditions, the dermal LDo of the test substance UNDECYLENATE DE METHYLE (batch No. 9810006) is equal to or higher than 2000 mg/kg in rats.